SGA
Strategic Global Advisors Portfolio holdings
AUM
$614M
This Quarter Return
+16.63%
1 Year Return
+31.57%
3 Year Return
+116.04%
5 Year Return
+189.12%
10 Year Return
+436.6%
AUM
$614M
AUM Growth
+$614M
(+22%)
Cap. Flow
+$44.3M
Cap. Flow
% of AUM
7.22%
Top 10 Holdings %
Top 10 Hldgs %
33.35%
Holding
148
New
11
Increased
111
Reduced
13
Closed
8
Top Buys
| 1 |
NXP Semiconductors
NXPI
|
$6.13M |
| 2 |
Philip Morris
PM
|
$5.39M |
| 3 |
Idexx Laboratories
IDXX
|
$4.62M |
| 4 |
Leidos
LDOS
|
$3.68M |
| 5 |
Maplebear
CART
|
$3.47M |
Top Sells
| 1 |
Amazon
AMZN
|
$5.58M |
| 2 |
CACI
CACI
|
$5.18M |
| 3 |
Amphenol
APH
|
$4.96M |
| 4 |
Texas Pacific Land
TPL
|
$2.54M |
| 5 |
Bristol-Myers Squibb
BMY
|
$2.45M |
Sector Composition
| 1 | Technology | 35.75% |
| 2 | Communication Services | 17.27% |
| 3 | Financials | 13.28% |
| 4 | Healthcare | 9.14% |
| 5 | Consumer Discretionary | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Infosys
INFY
$69.6B
| $507K | 0.08% |
27,380
-36,210
| -57% | -$671K |
|
127
XP
XP
$9.35B
| $507K | 0.08% |
+25,098
| New | +$507K |
|
128
Ambev
ABEV
$34.6B
| $471K | 0.08% |
195,549
+34,519
| +21% | +$83.2K |
|
129
HSBC
HSBC
$222B
| $469K | 0.08% |
7,715
+923
| +14% | +$56.1K |
|
130
Suncor Energy
SU
$50.2B
| $434K | 0.07% |
+11,594
| New | +$434K |
|
131
iShares MSCI India ETF
INDA
$9.23B
| $419K | 0.07% |
7,520
| – | – |
|
132
Qiagen
QGEN
$10.2B
| $414K | 0.07% |
8,615
+1,024
| +13% | +$49.2K |
|
133
Banco Santander
SAN
$139B
| $394K | 0.06% |
+47,465
| New | +$394K |
|
134
SK Telecom
SKM
$8.29B
| $383K | 0.06% |
16,386
| – | – |
|
135
TotalEnergies
TTE
$137B
| $334K | 0.05% |
5,435
+632
| +13% | +$38.8K |
|
136
KB Financial Group
KB
$28.4B
| $283K | 0.05% |
+3,430
| New | +$283K |
|
137
Nice
NICE
$8.65B
| $231K | 0.04% |
+1,369
| New | +$231K |
|
138
AstraZeneca
AZN
$249B
| $226K | 0.04% |
3,228
+313
| +11% | +$21.9K |
|
139
Teva Pharmaceuticals
TEVA
$21.1B
| $172K | 0.03% |
+10,288
| New | +$172K |
|
140
BRF SA
BRFS
$5.91B
| $43.8K | 0.01% |
+12,000
| New | +$43.8K |
|
|
141
Amphenol
APH
$131B
| – | – |
-75,658
| Closed | -$4.96M |
|
142
Booz Allen Hamilton
BAH
$13.4B
| – | – |
-6,232
| Closed | -$652K |
|
|
143
Bristol-Myers Squibb
BMY
$97B
| – | – |
-40,222
| Closed | -$2.45M |
|
144
DocuSign
DOCU
$15.1B
| – | – |
-21,801
| Closed | -$1.77M |
|
145
InMode
INMD
$925M
| – | – |
-20,744
| Closed | -$368K |
|
146
Neurocrine Biosciences
NBIX
$14B
| – | – |
-19,830
| Closed | -$2.19M |
|
147
Novo Nordisk
NVO
$254B
| – | – |
-7,343
| Closed | -$510K |
|
|
148
Texas Pacific Land
TPL
$22B
| – | – |
-1,920
| Closed | -$2.54M |
|